Search
Kumar C. Kibble will be the keynote speaker for The Partnership for Safe Medicine’s Interchange on October 27, 2011 at the National Press Club.
Kumar C. Kibble is the deputy director for U.S. Immigration and Customs Enforcement (ICE). In that capacity, he is the chief operating officer for the principal investigative agency of the Department of Homeland Security, with more than 20,000 employees assigned to more than 400 offices worldwide and an annual budget of almost $6 billion.
INTERPOL is using music to raise consumer awareness of the risks and prevalence of counterfeit medications in Africa. INTERPOL is launching a song, “Proud To Be,” by South African music star Yvonne Chaka Chaka featuring Youssou N’Dour on October 27, 2011 at the Hotel Hilton in Nairobi, Kenya. Chaka Chaka, known as the Princess of Africa, will perform live at…
Read More
The International Alliance of Patients’ Organizations (IAPO) conducted a seminar to build better understanding of patients needs in Pacific-Asia including the risks of counterfeit medications. “Patients should be the local leaders of a whole of society approach to tackling the pressing healthcare challenges of today,” announced IAPO at the seminar in Manilla, Philippines. The IAPO Seminar addressed to major healthcare…
Read More
Amgen discovers, develops, manufactures, and delivers innovative human therapeutics. A biotechnology pioneer since 1980, Amgen was one of the first companies to realize the new science’s promise by bringing safe, effective medicines from lab to manufacturing plant to patient. Amgen therapeutics have changed the practice of medicine, helping millions of people around the world in the fight against cancer, kidney…
Read More
Xuanhao Chan, lead technical officer for the International Pharmaceutical Federation, will join panelists on “The role of Patients and Healthcare Professionals” at the Partnership for Safe Medicine Interchange on October 27, 2011.
Chan is a registered pharmacist from Singapore and for the past 6 years, he has been working for the International Pharmaceutical Federation (FIP) in various positions. More recently, in 2008 he established the first branch office for FIP in Geneva managing the Federation’s global public health partnerships and serves as the FIP advocacy focal point with the World Health Organization (WHO) and other international health-related agencies in Geneva, Switzerland.
